New combination therapy shows promise for bladder cancer patients unresponsive to standard treatment
In an advance that could transform bladder cancer treatment, a novel combination of cretostimogene grenadenorepvec and pembrolizumab has shown remarkable efficacy in patients with Bacillus Calmette-Guérin (BCG)-unresponsive ...
Jun 6, 2024
0
97